-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction: The recently released results of a prospective study on chronic diseases in China suggest that comorbidities have become an important issue affecting the health of the Chinese population
.
The study analyzed about 25,000 people in 10 regions that participated in the two surveys.
In the past 10 years, residents with an average age of 52 have increased the comorbidity rate from 33.
5% to 58.
1%, and the per capita prevalence has increased from 1.
15 to 58.
1%.
1.
82 cases, with an average increase of 0.
42 cases every 5 years
.
What are the top five chronic diseases? Based on self-reported disease history, on-site physical examination and blood sample testing, researchers have defined 13 chronic diseases or health problems, and comorbidities are defined as having ≥ 2 chronic diseases or health problems at the same time
.
When the study population received the two surveys before and after, the comorbidity rates of people ≥65 years old were 50.
6% and 74.
3%, respectively
.
The top five chronic diseases with prevalence are overweight/obesity, hypertension, chronic obstructive pulmonary disease, biliary diseases and diabetes
.
Studies have found that the elderly, urban residents, and people with low education have a higher comorbidity rate, and the number of diseases increases faster with age
.
In addition, the number of people who smoke and drink excessively is increasing faster with age
.
The most common combination of comorbidities in this population is overweight/obesity, hypertension, diabetes, stroke, and coronary heart disease
.
The prevalence of the 13 chronic diseases or health problems included in the analysis during the baseline survey was 0.
4% to 50.
2%, and the prevalence of most diseases increased to varying degrees during the second repeat survey
.
Source: Sun Zhijia, Fan Junning, Yu Canqing, etc.
on behalf of the China Chronic Disease Prospective Research Project Cooperative Group.
Analysis of the epidemiological characteristics of adult comorbidities in 10 regions of China.
Chinese Journal of Epidemiology, 2021, 42(5): 755-762.
Reprinted From: China Recycling Magazine
